Observational studyOncology research2026

Efficacy and Safety of Durvalumab plus Tremelimumab for Unresectable Hepatocellular Carcinoma: A Real-World Multicenter Observational Study.

Krittiya Korphaisarn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.